Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Assessing the impact of the addition of pyriproxyfen on the durability of permethrin-treated bed nets in Burkina Faso: a compound-randomized controlled trial.

Toé KH, Mechan F, Tangena JA, Morris M, Solino J, Tchicaya EFS, Traoré A, Ismail H, Maas J, Lissenden N, Pinder M, Lindsay SW, Tiono AB, Ranson H, Sagnon N.

Malar J. 2019 Dec 2;18(1):383. doi: 10.1186/s12936-019-3018-1.

2.

Investigating the impact of enhanced community case management and monthly screening and treatment on the transmissibility of malaria infections in Burkina Faso: study protocol for a cluster-randomised trial.

Collins KA, Ouedraogo A, Guelbeogo WM, Awandu SS, Stone W, Soulama I, Ouattara MS, Nombre A, Diarra A, Bradley J, Selvaraj P, Gerardin J, Drakeley C, Bousema T, Tiono A.

BMJ Open. 2019 Sep 13;9(9):e030598. doi: 10.1136/bmjopen-2019-030598.

3.

CYP2D6 Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparum.

Pett H, Bradley J, Okebe J, Dicko A, Tiono AB, Gonçalves BP, Stone W, Chen I, Lanke K, Neuvonen M, Mustaniemi AL, Eziefula AC, Gosling R, D'Alessandro U, Drakeley C, Niemi M, Bousema T.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e00538-19. doi: 10.1128/AAC.00538-19. Print 2019 Oct.

4.

Author Correction: The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density.

Slater HC, Ross A, Felger I, Hofmann NE, Robinson L, Cook J, Gonçalves BP, Björkman A, Ouedraogo AL, Morris U, Msellem M, Koepfli C, Mueller I, Tadesse F, Gadisa E, Das S, Domingo G, Kapulu M, Midega J, Owusu-Agyei S, Nabet C, Piarroux R, Doumbo O, Doumbo SN, Koram K, Lucchi N, Udhayakumar V, Mosha J, Tiono A, Chandramohan D, Gosling R, Mwingira F, Sauerwein R, Paul R, Riley EM, White NJ, Nosten F, Imwong M, Bousema T, Drakeley C, Okell LC.

Nat Commun. 2019 Jun 11;10(1):2644. doi: 10.1038/s41467-019-10790-0.

5.

Functional antibodies against Plasmodium falciparum sporozoites are associated with a longer time to qPCR-detected infection among schoolchildren in Burkina Faso.

Barry A, Behet MC, Nébié I, Lanke K, Grignard L, Ouedraogo A, Soulama I, Drakeley C, Sauerwein R, Bolscher JM, Dechering KJ, Bousema T, Tiono AB, Gonçalves BP.

Version 2. Wellcome Open Res. 2019 May 1 [revised 2019 Jan 1];3:159. doi: 10.12688/wellcomeopenres.14932.2. eCollection 2018.

6.

The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density.

Slater HC, Ross A, Felger I, Hofmann NE, Robinson L, Cook J, Gonçalves BP, Björkman A, Ouedraogo AL, Morris U, Msellem M, Koepfli C, Mueller I, Tadesse F, Gadisa E, Das S, Domingo G, Kapulu M, Midega J, Owusu-Agyei S, Nabet C, Piarroux R, Doumbo O, Doumbo SN, Koram K, Lucchi N, Udhayakumar V, Mosha J, Tiono A, Chandramohan D, Gosling R, Mwingira F, Sauerwein R, Paul R, Riley EM, White NJ, Nosten F, Imwong M, Bousema T, Drakeley C, Okell LC.

Nat Commun. 2019 Mar 29;10(1):1433. doi: 10.1038/s41467-019-09441-1. Erratum in: Nat Commun. 2019 Jun 11;10(1):2644.

7.

A Phase II, Randomized, Double-blind, Controlled Safety and Immunogenicity Trial of Typhoid Conjugate Vaccine in Children Under 2 Years of Age in Ouagadougou, Burkina Faso: A Methods Paper.

Laurens MB, Sirima SB, Rotrosen ET, Siribie M, Tiono A, Ouedraogo A, Liang Y, Jamka LP, Kotloff KL, Neuzil KM.

Clin Infect Dis. 2019 Mar 7;68(Supplement_2):S59-S66. doi: 10.1093/cid/ciy1104.

8.

Bead-based assays to simultaneously detect multiple human inherited blood disorders associated with malaria.

Grignard L, Mair C, Curry J, Mahey L, Bastiaens GJH, Tiono AB, Okebe J, Coulibaly SA, Gonçalves BP, Affara M, Ouédraogo A, Bougouma EC, Sanou GS, Nébié I, Lanke KHW, Sirima SB, d'Alessandro U, Clark TG, Campino S, Bousema T, Drakeley C.

Malar J. 2019 Jan 21;18(1):14. doi: 10.1186/s12936-019-2648-7.

9.

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.

Tiono AB, Nébié I, Anagnostou N, Coulibaly AS, Bowyer G, Lam E, Bougouma EC, Ouedraogo A, Yaro JBB, Barry A, Roberts R, Rampling T, Bliss C, Hodgson S, Lawrie A, Ouedraogo A, Imoukhuede EB, Ewer KJ, Viebig NK, Diarra A, Leroy O, Bejon P, Hill AVS, Sirima SB.

PLoS One. 2018 Dec 12;13(12):e0208328. doi: 10.1371/journal.pone.0208328. eCollection 2018.

10.

Efficacy of Olyset Duo, a bednet containing pyriproxyfen and permethrin, versus a permethrin-only net against clinical malaria in an area with highly pyrethroid-resistant vectors in rural Burkina Faso: a cluster-randomised controlled trial.

Tiono AB, Ouédraogo A, Ouattara D, Bougouma EC, Coulibaly S, Diarra A, Faragher B, Guelbeogo MW, Grisales N, Ouédraogo IN, Ouédraogo ZA, Pinder M, Sanon S, Smith T, Vanobberghen F, Sagnon N, Ranson H, Lindsay SW.

Lancet. 2018 Aug 18;392(10147):569-580. doi: 10.1016/S0140-6736(18)31711-2. Epub 2018 Aug 10. Erratum in: Lancet. 2018 Aug 25;392(10148):636.

PMID:
30104047
11.

Haemolysis and haem oxygenase-1 induction during persistent "asymptomatic" malaria infection in Burkinabé children.

Mooney JP, Barry A, Gonçalves BP, Tiono AB, Awandu SS, Grignard L, Drakeley CJ, Bottomley C, Bousema T, Riley EM.

Malar J. 2018 Jul 6;17(1):253. doi: 10.1186/s12936-018-2402-6.

12.

Predicting the likelihood and intensity of mosquito infection from sex specific Plasmodium falciparum gametocyte density.

Bradley J, Stone W, Da DF, Morlais I, Dicko A, Cohuet A, Guelbeogo WM, Mahamar A, Nsango S, Soumaré HM, Diawara H, Lanke K, Graumans W, Siebelink-Stoter R, van de Vegte-Bolmer M, Chen I, Tiono A, Gonçalves BP, Gosling R, Sauerwein RW, Drakeley C, Churcher TS, Bousema T.

Elife. 2018 May 31;7. pii: e34463. doi: 10.7554/eLife.34463.

13.

Transmission of molecularly undetectable circulating parasite clones leads to high infection complexity in mosquitoes post feeding.

Grignard L, Gonçalves BP, Early AM, Daniels RF, Tiono AB, Guelbéogo WM, Ouédraogo A, van Veen EM, Lanke K, Diarra A, Nebie I, Sirima SB, Targett GA, Volkman SK, Neafsey DE, Wirth DF, Bousema T, Drakeley C.

Int J Parasitol. 2018 Jul;48(8):671-677. doi: 10.1016/j.ijpara.2018.02.005. Epub 2018 May 5.

14.

Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials.

Bastiaens GJH, Tiono AB, Okebe J, Pett HE, Coulibaly SA, Gonçalves BP, Affara M, Ouédraogo A, Bougouma EC, Sanou GS, Nébié I, Bradley J, Lanke KHW, Niemi M, Sirima SB, d'Alessandro U, Bousema T, Drakeley C.

PLoS One. 2018 Jan 11;13(1):e0190272. doi: 10.1371/journal.pone.0190272. eCollection 2018.

15.

Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity.

Gonçalves BP, Kapulu MC, Sawa P, Guelbéogo WM, Tiono AB, Grignard L, Stone W, Hellewell J, Lanke K, Bastiaens GJH, Bradley J, Nébié I, Ngoi JM, Oriango R, Mkabili D, Nyaurah M, Midega J, Wirth DF, Marsh K, Churcher TS, Bejon P, Sirima SB, Drakeley C, Bousema T.

Nat Commun. 2017 Oct 26;8(1):1133. doi: 10.1038/s41467-017-01270-4.

16.

A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria.

Macintyre F, Adoke Y, Tiono AB, Duong TT, Mombo-Ngoma G, Bouyou-Akotet M, Tinto H, Bassat Q, Issifou S, Adamy M, Demarest H, Duparc S, Leroy D, Laurijssens BE, Biguenet S, Kibuuka A, Tshefu AK, Smith M, Foster C, Leipoldt I, Kremsner PG, Phuc BQ, Ouedraogo A, Ramharter M; OZ-Piperaquine Study Group.

BMC Med. 2017 Oct 9;15(1):181. doi: 10.1186/s12916-017-0940-3.

17.

Antibody responses to P. falciparum blood stage antigens and incidence of clinical malaria in children living in endemic area in Burkina Faso.

Cherif MK, Ouédraogo O, Sanou GS, Diarra A, Ouédraogo A, Tiono A, Cavanagh DR, Michael T, Konaté AT, Watson NL, Sanza M, Dube TJT, Sirima SB, Nebié I.

BMC Res Notes. 2017 Sep 8;10(1):472. doi: 10.1186/s13104-017-2772-9.

18.

Molecular Markers for Sensitive Detection of Plasmodium falciparum Asexual Stage Parasites and their Application in a Malaria Clinical Trial.

Tadesse FG, Lanke K, Nebie I, Schildkraut JA, Gonçalves BP, Tiono AB, Sauerwein R, Drakeley C, Bousema T, Rijpma SR.

Am J Trop Med Hyg. 2017 Jul;97(1):188-198. doi: 10.4269/ajtmh.16-0893.

19.

Immunogenicity and Safety of 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children With Sickle Cell Disease Between 8 Weeks and 2 Years of Age: A Phase III, Open, Controlled Study.

Sirima SB, Tiono A, Gansané Z, Siribié M, Zongo A, Ouédraogo A, François N, Strezova A, Dobbelaere K, Borys D.

Pediatr Infect Dis J. 2017 May;36(5):e136-e150. doi: 10.1097/INF.0000000000001518.

PMID:
28403055
20.

Pregnant Women: An Overlooked Asset to Plasmodium falciparum Malaria Elimination Campaigns?

Gonçalves BP, Walker PG, Cairns M, Tiono AB, Bousema T, Drakeley C.

Trends Parasitol. 2017 Jul;33(7):510-518. doi: 10.1016/j.pt.2017.03.001. Epub 2017 Mar 27. Review.

PMID:
28359609
21.

Age, Weight, and CYP2D6 Genotype Are Major Determinants of Primaquine Pharmacokinetics in African Children.

Gonçalves BP, Pett H, Tiono AB, Murry D, Sirima SB, Niemi M, Bousema T, Drakeley C, Ter Heine R.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02590-16. doi: 10.1128/AAC.02590-16. Print 2017 May.

22.

An epidemiological study to assess Plasmodium falciparum parasite prevalence and malaria control measures in Burkina Faso and Senegal.

Diallo A, Sié A, Sirima S, Sylla K, Ndiaye M, Bountogo M, Ouedraogo E, Tine R, Ndiaye A, Coulibaly B, Ouedraogo A, Faye B, Ba EH, Compaore G, Tiono A, Sokhna C, Yé M, Diarra A, Bahmanyar ER, De Boer M, Pirçon JY, Usuf EA.

Malar J. 2017 Feb 6;16(1):63. doi: 10.1186/s12936-017-1715-1.

23.

Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants.

Bliss CM, Drammeh A, Bowyer G, Sanou GS, Jagne YJ, Ouedraogo O, Edwards NJ, Tarama C, Ouedraogo N, Ouedraogo M, Njie-Jobe J, Diarra A, Afolabi MO, Tiono AB, Yaro JB, Adetifa UJ, Hodgson SH, Anagnostou NA, Roberts R, Duncan CJ, Cortese R, Viebig NK, Leroy O, Lawrie AM, Flanagan KL, Kampmann B, Imoukhuede EB, Sirima SB, Bojang K, Hill AV, Nébié I, Ewer KJ.

Mol Ther. 2017 Feb 1;25(2):547-559. doi: 10.1016/j.ymthe.2016.11.003.

24.

Impact of Improving Community-Based Access to Malaria Diagnosis and Treatment on Household Costs.

Castellani J, Nsungwa-Sabiiti J, Mihaylova B, Ajayi IO, Siribié M, Afonne C, Balyeku A, Sermé L, Sanou AK, Sombié BS, Tiono AB, Sirima SB, Kabarungi V, Falade CO, Kyaligonza J, Evers SM, Paulus AT, Petzold M, Singlovic J, Gomes M.

Clin Infect Dis. 2016 Dec 15;63(suppl 5):S256-S263.

25.

Feasibility of Malaria Diagnosis and Management in Burkina Faso, Nigeria, and Uganda: A Community-Based Observational Study.

Ajayi IO, Nsungwa-Sabiiti J, Siribié M, Falade CO, Sermé L, Balyeku A, Afonne C, Sanou AK, Kabarungi V, Oshiname FO, Gansane Z, Kyaligonza J, Jegede AS, Tiono AB, Sirima SB, Diarra A, Yusuf OB, Fouque F, Castellani J, Petzold M, Singlovic J, Gomes M.

Clin Infect Dis. 2016 Dec 15;63(suppl 5):S245-S255.

26.

Using health and demographic surveillance systems for teratovigilance in Africa.

Kirakoya-Samadoulougou F, Sombié I, Ogutu B, Tinto H, Kouanda S, Tiono AB, Otieno W, Dodoo A, Kamanda M, Sankoh O.

Lancet Glob Health. 2016 Dec;4(12):e906. doi: 10.1016/S2214-109X(16)30252-2. No abstract available.

27.

Comparison of molecular quantification of Plasmodium falciparum gametocytes by Pfs25 qRT-PCR and QT-NASBA in relation to mosquito infectivity.

Pett H, Gonçalves BP, Dicko A, Nébié I, Tiono AB, Lanke K, Bradley J, Chen I, Diawara H, Mahamar A, Soumare HM, Traore SF, Baber I, Sirima SB, Sauerwein R, Brown J, Gosling R, Felger I, Drakeley C, Bousema T.

Malar J. 2016 Nov 8;15(1):539.

28.

A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children.

Sirima SB, Mordmüller B, Milligan P, Ngoa UA, Kironde F, Atuguba F, Tiono AB, Issifou S, Kaddumukasa M, Bangre O, Flach C, Christiansen M, Bang P, Chilengi R, Jepsen S, Kremsner PG, Theisen M; GMZ2 Trial Study Group.

Vaccine. 2016 Aug 31;34(38):4536-4542. doi: 10.1016/j.vaccine.2016.07.041. Epub 2016 Jul 28.

29.

Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants.

Afolabi MO, Tiono AB, Adetifa UJ, Yaro JB, Drammeh A, Nébié I, Bliss C, Hodgson SH, Anagnostou NA, Sanou GS, Jagne YJ, Ouedraogo O, Tamara C, Ouedraogo N, Ouedraogo M, Njie-Jobe J, Diarra A, Duncan CJ, Cortese R, Nicosia A, Roberts R, Viebig NK, Leroy O, Lawrie AM, Flanagan KL, Kampman B, Bejon P, Imoukhuede EB, Ewer KJ, Hill AV, Bojang K, Sirima SB.

Mol Ther. 2016 Aug;24(8):1470-7. doi: 10.1038/mt.2016.83. Epub 2016 Apr 25.

30.

Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial.

Gonçalves BP, Tiono AB, Ouédraogo A, Guelbéogo WM, Bradley J, Nebie I, Siaka D, Lanke K, Eziefula AC, Diarra A, Pett H, Bougouma EC, Sirima SB, Drakeley C, Bousema T.

BMC Med. 2016 Mar 8;14:40. doi: 10.1186/s12916-016-0581-y.

31.

Clinical Variation of Plasmodium falciparum eba-175, ama-1, and msp-3 Genotypes in Young Children Living in a Seasonally High Malaria Transmission Setting in Burkina Faso.

Soulama I, Sermé SS, Bougouma EC, Diarra A, Tiono AB, Ouedraogo A, Konate AT, Nebie I, Sirima SB.

J Parasitol Res. 2015;2015:985651. doi: 10.1155/2015/985651. Epub 2015 Nov 8.

32.
33.

[Effect of a large scale community-based distribution of artemether-lumefantrine on its therapeutic efficacy among children living in a rural area of Burkina Faso].

Siribié M, Diarra A, Tiono AB, Soulama I, Sirima SB.

Bull Soc Pathol Exot. 2015 Mar;108(2):120-3. doi: 10.1007/s13149-015-0420-y. Epub 2015 Feb 27. French.

PMID:
25925810
34.

Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®).

Tiono AB, Tinto H, Alao MJ, Meremikwu M, Tshefu A, Ogutu B, Ouedraogo A, Lingani M, Cousin M, Lefèvre G, Jain JP, Duparc S, Hamed K.

Malar J. 2015 Apr 15;14:157. doi: 10.1186/s12936-015-0682-7.

35.

Comparison of azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study.

Chandra R, Ansah P, Sagara I, Sie A, Tiono AB, Djimde AA, Zhao Q, Robbins J, Penali LK, Ogutu B.

Malar J. 2015 Mar 10;14:108. doi: 10.1186/s12936-015-0620-8.

37.

Novel Insights Into the Protective Role of Hemoglobin S and C Against Plasmodium falciparum Parasitemia.

Mangano VD, Kabore Y, Bougouma EC, Verra F, Sepulveda N, Bisseye C, Santolamazza F, Avellino P, Tiono AB, Diarra A, Nebie I, Rockett KA, Sirima SB, Modiano D; MalariaGEN Consortium.

J Infect Dis. 2015 Aug 15;212(4):626-34. doi: 10.1093/infdis/jiv098. Epub 2015 Feb 23.

38.

Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.

Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW.

Malar J. 2014 Nov 25;13:458. doi: 10.1186/1475-2875-13-458.

39.

Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial.

Ouédraogo AL, Bastiaens GJ, Tiono AB, Guelbéogo WM, Kobylinski KC, Ouédraogo A, Barry A, Bougouma EC, Nebie I, Ouattara MS, Lanke KH, Fleckenstein L, Sauerwein RW, Slater HC, Churcher TS, Sirima SB, Drakeley C, Bousema T.

Clin Infect Dis. 2015 Feb 1;60(3):357-65. doi: 10.1093/cid/ciu797. Epub 2014 Nov 19. Erratum in: Clin Infect Dis. 2016 Sep 1;63(5):715.

PMID:
25414262
40.

Plasmodium falciparum malaria in children aged 0-2 years: the role of foetal haemoglobin and maternal antibodies to two asexual malaria vaccine candidates (MSP3 and GLURP).

Kangoye DT, Nebie I, Yaro JB, Debe S, Traore S, Ouedraogo O, Sanou G, Soulama I, Diarra A, Tiono A, Marsh K, Sirima SB, Bejon P.

PLoS One. 2014 Sep 19;9(9):e107965. doi: 10.1371/journal.pone.0107965. eCollection 2014.

41.

Erratum to: Low Specificity of a Malaria Rapid Diagnostic Test During an Integrated Community Case Management Trial.

Tiono AB, Diarra A, Sanon S, Nébié I, Konaté AT, Pagnoni F, Sirima SB.

Infect Dis Ther. 2013 Dec;2(2):227. doi: 10.1007/s40121-013-0017-3. No abstract available.

42.

Novel genotyping tools for investigating transmission dynamics of Plasmodium falciparum.

Wampfler R, Timinao L, Beck HP, Soulama I, Tiono AB, Siba P, Mueller I, Felger I.

J Infect Dis. 2014 Oct 15;210(8):1188-97. doi: 10.1093/infdis/jiu236. Epub 2014 Apr 25.

43.

Assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors.

Nébié I, Edwards NJ, Tiono AB, Ewer KJ, Sanou GS, Soulama I, Sanon S, Diarra A, Yaro JB, Kangoye D, Imoukhuede EB, Hill AV, Sirima SB.

Clin Vaccine Immunol. 2014 Jun;21(6):901-3. doi: 10.1128/CVI.00723-13. Epub 2014 Apr 16. Erratum in: Clin Vaccine Immunol. 2014 Sep;21(9):1376.

44.

Malaria incidence in children in South-West Burkina Faso: comparison of active and passive case detection methods.

Tiono AB, Kangoye DT, Rehman AM, Kargougou DG, Kaboré Y, Diarra A, Ouedraogo E, Nébié I, Ouédraogo A, Okech B, Milligan P, Sirima SB.

PLoS One. 2014 Jan 24;9(1):e86936. doi: 10.1371/journal.pone.0086936. eCollection 2014.

45.

Lessons learned from the use of HRP-2 based rapid diagnostic test in community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso.

Tiono AB, Ouédraogo A, Diarra A, Coulibaly S, Soulama I, Konaté AT, Barry A, Mukhopadhyay A, Sirima SB, Hamed K.

Malar J. 2014 Jan 27;13:30. doi: 10.1186/1475-2875-13-30.

46.

Laboratory evaluation of Fendona 6SC treated bednets and Interceptor long-lasting nets against Anopheles gambiae s.l. in Burkina Faso.

Badolo A, Guelbéogo WM, Tiono AB, Traoré A, Sagnon N, Sirima SB.

Parasitol Res. 2014 Mar;113(3):1069-75. doi: 10.1007/s00436-013-3742-3. Epub 2014 Jan 15.

PMID:
24425451
47.

A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of age.

Ouédraogo A, Tiono AB, Kargougou D, Yaro JB, Ouédraogo E, Kaboré Y, Kangoye D, Bougouma EC, Gansane A, Henri N, Diarra A, Sanon S, Soulama I, Konate AT, Watson NL, Brown V, Hendriks J, Pau MG, Versteege I, Wiesken E, Sadoff J, Nebie I, Sirima SB.

PLoS One. 2013 Nov 11;8(11):e78679. doi: 10.1371/journal.pone.0078679. eCollection 2013.

49.

Variation in haematological parameters in children less than five years of age with asymptomatic Plasmodium infection: implication for malaria field studies.

Gansane A, Ouedraogo IN, Henry NB, Soulama I, Ouedraogo E, Yaro JB, Diarra A, Benjamin S, Konate AT, Tiono A, Sirima SB.

Mem Inst Oswaldo Cruz. 2013 Aug;108(5):644-50.

50.

Treatment of Asymptomatic Carriers of Plasmodium falciparum with Artemether-Lumefantrine: Impact on the Prevalence of Anemia.

Tiono AB, Ouédraogo A, Remy C, Hamed K.

Infect Dis Ther. 2013 Jun;2(1):47-58. doi: 10.1007/s40121-013-0005-7. Epub 2013 Mar 30.

Supplemental Content

Support Center